Ampullary carcinoma
Clinical trials for Ampullary carcinoma explained in plain language.
Never miss a new study
Get alerted when new Ampullary carcinoma trials appear
Sign up with your email to follow new studies for Ampullary carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a targeted pill shrink hard-to-treat bile duct cancers?
Disease control Not yet recruitingThis phase 2 trial tests whether daraxonrasib, an oral drug that targets cancers with a KRAS mutation, can shrink tumors in people with advanced biliary tract cancer that has progressed after first-line treatment. Participants take the drug once daily in 28-day cycles. The main g…
Matched conditions: AMPULLARY CARCINOMA
Phase 2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Smartwatch-Guided prehab aims to boost pancreatic surgery recovery
Disease control Not yet recruitingThis trial tests whether a wearable device and a personalized prehabilitation program can help adults recover better after surgery for pancreatic cancer or related conditions. Participants will wear a monitor to track vital signs and activity, and follow a program of exercise, nu…
Matched conditions: AMPULLARY CARCINOMA
Sponsor: Manchester University NHS Foundation Trust • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New drainage technique may reduce pancreatitis risk after tumor surgery
Disease control Not yet recruitingThis study tests whether using a gentle suction tube (negative-pressure drainage) is better than placing a small plastic tube (stent) in the pancreas to prevent pancreatitis after removing tumors from the duodenum. About 132 adults with early-stage tumors will be randomly assigne…
Matched conditions: AMPULLARY CARCINOMA
Sponsor: Cui Xiaobing • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC